NASDAQ:DMAQ Deep Medicine Acquisition (DMAQ) Stock Price, News & Analysis → Biden Nomination CANCELED? (From The Freeport Society) (Ad) Free DMAQ Stock Alerts $2.96 -5.43 (-64.72%) (As of 01/31/2024) Add Compare Share Share Today's Range$2.96▼$8.0050-Day Range$1.15▼$2.9652-Week Range$2.96▼$19.91Volume104,900 shsAverage Volume44,644 shsMarket Capitalization$12.90 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsOwnershipSEC FilingsSocial MediaStock AnalysisChartFinancialsOwnershipSEC FilingsSocial Media Ad Manward PressShocking: One AI startup's revenue could surge 4,735%Shocking: One AI Startup's Revenue Could Surge 4,735% While Nvidia gets all the attention, one small AI startup is quietly positioning itself to be the biggest winner.Click here to discover the AI chip company About Deep Medicine AcquisitionDeep Medicine Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on identifying businesses in the healthcare industry. Deep Medicine Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Deep Medicine Acquisition Corp. operates as subsidiary of Bright Vision Sponsor LLC.Read More DMAQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DMAQ Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Company Calendar Today5/19/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:DMAQ CUSIPN/A CIK1857086 WebN/A Phone917-289-2776FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares4,358,000Free Float4,284,000Market Cap$5.97 million OptionableNot Optionable Beta0.02 Key ExecutivesMr. Humphrey P. Polanen (Age 74)CEO & Chairman of the Board Ms. Weixuan Luo CPA (Age 51)MS, Chief Financial Officer Key CompetitorsHealthcare AI AcquisitionNASDAQ:HAIAMaxpro Capital AcquisitionNASDAQ:JMACMountain Crest Acquisition Corp. IIINASDAQ:MCAEEF Hutton Acquisition Co. INASDAQ:EFHTRedwoods AcquisitionNASDAQ:RWODView All Competitors DMAQ Stock Analysis - Frequently Asked Questions How have DMAQ shares performed in 2024? Deep Medicine Acquisition's stock was trading at $11.65 at the beginning of 2024. Since then, DMAQ shares have decreased by 74.6% and is now trading at $2.96. View the best growth stocks for 2024 here. How do I buy shares of Deep Medicine Acquisition? Shares of DMAQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DMAQ) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceDems have chosen Biden replacement?Paradigm PressBill Gates is all about this tiny $2 stockTimothy SykesDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist My Default Watchlist Adding Deep Medicine Acquisition Corp. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
